The final results pinpointed the vital role of the POLD1 gene in the prognosis of ccRCC and illustrated a relevance between POLD1 expression and the clinical outcome of the ccRCC cohort as well as the tumor-infiltrating immune cells. This evidence concerns the gene POLD1 and neoplasm.